Kirk Dornbush
Gründer bei Iconic Therapeutics, Inc.
Profil
Kirk Dornbush is the founder and the Director of Iconic Therapeutics, Inc., which was founded in 2003.
He is currently a Manager at Diem Bioventures LLC.
Mr. Dornbush has an undergraduate degree from The Colorado College and a graduate degree from Boston University School of Law.
Aktive Positionen von Kirk Dornbush
| Unternehmen | Position | Beginn |
|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Gründer | 01.01.2003 |
Diem Bioventures LLC
 Diem Bioventures LLC Investment ManagersFinance Diem Bioventures LLC provides investment advisory services. The company was founded on January 28, 2003 and is headquartered in Highlands, NC. | Corporate Officer/Principal | - |
Ausbildung von Kirk Dornbush
| The Colorado College | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Diem Bioventures LLC
Diem Bioventures LLC Investment ManagersFinance Diem Bioventures LLC provides investment advisory services. The company was founded on January 28, 2003 and is headquartered in Highlands, NC. | Finance |
